A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003

Clinical trial NCT04627155 · COMPLETED

Trial details

NCT number: NCT04627155
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2013-03-15
Primary completion: 2013-05-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.